A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

por Byers, Lauren Averett, Horn, Leora, Ghandi, Jitendra, Kloecker, Goetz, Owonikoko, Taofeek, Waqar, Saiama Naheed, Krzakowski, Maciej, Cardnell, Robert J., Fujimoto, Junya, Taverna, Pietro, Azab, Mohammad, Camidge, David Ross
Publicado 2017